Sri Sathya Sai Institute of Higher Learning (SSSIHL) has signed a strategic Memorandum of Understanding (MoU) with Promea Therapeutics Pvt. Ltd., a rapidly expanding healthcare and biopharmaceutical company. This partnership marks a significant milestone in strengthening the institute’s industry-academia interface and advancing translational research, skill development, and innovation in the healthcare and life sciences sectors.
Key Areas of Collaboration
This MoU will facilitate a range of collaborative activities designed to bridge academic excellence with industrial relevance:
- Industry-Integrated Training and Research: Promea will provide SSSIHL students with hands-on industrial training, project internships, and exposure to real-time challenges in pharmaceutical and medical device development.
- Joint Research Initiatives: Faculty and researchers from both institutions will co-develop projects in diagnostics, therapeutics, and biosimilars, translating scientific discoveries into real-world solutions.
- Sponsored Doctoral Programs: Promea will support industry-aligned PhD fellowships to promote cutting-edge research addressing national healthcare priorities.
- Shared Research Infrastructure: The collaboration includes access to SSSIHL’s Central Research Instruments Facility (CRIF) to support advanced R&D initiatives.
- Innovation to Commercialization: A joint focus on transforming research into tangible healthcare technologies with direct patient impact.
- Recruitment and Career Development: Promea will explore career and mentorship opportunities for SSSIHL students through placements and collaborative engagement.
MoU Signing Ceremony
The MoU was formally signed on 13 June 2025 at Promea Therapeutics Pvt. Ltd., in Hyderabad, between:
- Dr. Srikanth Khanna, Registrar, SSSIHL
- Mr. Gopi Lekkala, Director, Promea Therapeutics Pvt. Ltd.
The event was graced by:
- Prof. B. Raghavendra Prasad – Vice Chancellor, SSSIHL
- Prof. Pallav Kumar Baruah – Dean, Innovation & Entrepreneurship and President, Institution’s Innovation Council, SSSIHL
- Dr. B.E. Pradeep – Faculty Member, Department of Biosciences, SSSIHL
- Prof. Reddanna Pallu, Executive President, FABA, whose continued guidance and encouragement have been instrumental in advancing academia-industry engagement in the life sciences sector.
This collaboration is a reflection of SSSIHL’s commitment to values-based, research-driven education that not only fosters academic excellence but also cultivates socially relevant innovation. Through this partnership, both institutions aim to empower the next generation of scientists, researchers, and professionals to solve real-world healthcare challenges with compassion, competence, and creativity.
